WuXi Biologics Achieves ISO 20400 Certification
WuXi Biologics has recently announced a significant milestone in its commitment to sustainability by achieving ISO 20400 Sustainable Procurement certification. This internationally recognized standard demonstrates the company's dedication to integrating sustainability principles into its procurement practices and fostering transparency across its supply chain.
Commitment to Sustainable Practices
Dr. Chris Chen, the CEO of WuXi Biologics and Chairman of the ESG Committee, emphasizes the importance of adhering to world-class management strategies. These strategies aim to build a strong supply chain that embodies sustainable business growth. WuXi Biologics is dedicated to providing high-quality solutions that meet the global demands of its clients while actively contributing to responsible advancements in the pharmaceutical industry.
Enhancing Supplier Management
WuXi Biologics has embedded sustainability principles into every aspect of its supplier lifecycle management. This includes due diligence and admission processes, risk management, supplier engagement, and performance evaluations. With these measures in place, WuXi ensures that all suppliers meet quality and compliance standards while promoting sustainability throughout partnerships. This approach not only mitigates potential risks but also enhances operational efficiency.
Integrating Climate Strategies
The company recognizes the critical importance of addressing climate change challenges and has adopted a comprehensive approach with measurable targets. WuXi Biologics works closely with suppliers to implement sustainable supply chain management that positively impacts the entire value chain. Their commitment to environmental responsibility is evident in every facet of their operations.
Acknowledgments and Recognitions
As a member of the United Nations Global Compact, WuXi Biologics actively advocates for sustainability. The company has garnered numerous accolades for its efforts in this regard, including attaining an MSCI AAA Rating and receiving an EcoVadis Platinum Medal. Additionally, WuXi has been listed multiple times in the Dow Jones Sustainability Indices and recognized by the CDP for their climate change and water security initiatives. Their ongoing recognition as a top-rated company by Sustainalytics further cements their status as a leader in Environmental, Social, and Governance (ESG) matters.
Global Commitment with Local Roots
WuXi Biologics operates globally with over 12,000 skilled employees across various countries. This diverse workforce continues to provide cost-effective solutions for biologics discovery, development, and manufacturing. As of mid-2025, the company is supporting 864 integrated client projects, showcasing its robust collaborative capabilities.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK) is recognized as a leading global Contract Research, Development, and Manufacturing Organization (CRDMO). The company provides end-to-end solutions that enable partners to discover, develop, and manufacture biologics, catering to the specific needs of patients worldwide. WuXi Biologics places a strong emphasis on sustainability as a foundational aspect of long-term growth and innovation. It continuously utilizes green technologies to offer cutting-edge Green CRDMO solutions, firmly committed to creating shared value and fostering positive social and environmental impacts.
Frequently Asked Questions
What is ISO 20400 certification?
ISO 20400 is an international standard that provides guidelines on integrating sustainability into procurement processes, promoting responsible practices in supply chains.
What role does WuXi Biologics play in sustainability?
WuXi Biologics is committed to sustainable practices in its procurement and supply chain management, enhancing its environmental and social governance initiatives.
How does WuXi Biologics manage suppliers sustainably?
The company employs sustainability principles throughout its supplier lifecycle, ensuring compliance while promoting environmental responsibility among its partners.
What recognitions has WuXi Biologics received?
WuXi Biologics has achieved several accolades, including an MSCI AAA Rating, an EcoVadis Platinum Medal, and placement in the Dow Jones Sustainability Indices.
What services does WuXi Biologics offer?
WuXi Biologics offers comprehensive Contract Research, Development, and Manufacturing solutions, supporting the entire biologics lifecycle from development to commercialization.
